CDK4 and metaplastic breast carcinoma: MDM2 and/or CDK4 protein overexpression and gene amplification are beneficial ancillary studies that can help establish the diagnosis of primary breast ALT/WDLPS and DDLPS, and effectively rule out the diagnoses of malignant phyllodes tumor and metaplastic breast carcinoma [22].